Immunomodulatory Macroporous Scaffold based T Cell-Stimulating Platform Development Service

Online Inquiry

Background

Tumors evade immune attack by creating a microenvironment rich in regulatory T cells (Tregs), which suppress anti-tumor immunity. While current immunotherapies like targeting CTLA-4 and PD-1 can reduce Tregs and boost effector T cells, they can also have detrimental effects. A promising alternative involves implanting a biodegradable, sponge-like scaffold near the tumor. This scaffold is designed to locally eliminate Tregs and stimulate a powerful, body-wide anti-tumor response from effector T cells, offering a potentially revolutionary approach to cancer treatment.

Fig.1 Overview of suppressive mechanisms used by Tregs to create barriers to immune infiltration into tumors. Fig.1 Tregs employ diverse strategies to suppress anti-tumor immunity and hinder immune cell infiltration into tumors.¹

Key Features of Immunomodulatory Macroporous Scaffold

Immunomodulatory macroporous scaffolds offer promising potential for enhancing T cell activation, exhibiting key features such as:

Macroporous Structure:	These scaffolds' large pores (approximately 150 μm) promote T cell infiltration and movement, crucial for their activation and expansion within the scaffold.
Immunomodulatory Properties:	These scaffolds are engineered to stimulate the immune system, particularly T cells, either through the inclusion of immune-boosting substances or via the scaffold's inherent properties.
Controlled Release of Activation Cues:	The scaffolds can be engineered to release T cell activation signals in a controlled manner.
T cell-Responsiveness:	Certain scaffolds are engineered to respond to T cell activity, dynamically degrading or releasing their contents to further stimulate the immune response.
Biocompatibility and Biodegradability:	These biocompatible and biodegradable scaffolds, often composed of materials like alginate, safely degrade and are eliminated by the body over time.
ECM Mimicking:	Hydrogel-based scaffolds can mimic the extracellular matrix (ECM), providing a more natural environment for T cells to reside and become activated.
Functional Modifiability:	These scaffolds can be enhanced with molecules like IGF-1C or RGD to boost cell interactions and their immune-modulating capabilities.

Our Immunomodulatory Macroporous Scaffold based Artificial T Cell-Stimulating Platform Development Service

Creative Biolabs provides a custom service for developing artificial T cell-stimulating platforms using immunomodulatory macroporous scaffolds, accelerating cancer immunotherapy research. We specialize in designing and fabricating tailored scaffolds that mimic the natural T cell activation milieu. Our approach utilizes biocompatible and biodegradable materials to create scaffolds featuring interconnected macropores for optimal T cell infiltration, immunomodulatory properties to stimulate T cell activation, and controlled release systems for sustained delivery of activation signals like antibodies or cytokines. Our goal is to facilitate in situ T cell stimulation and activation, ultimately enhancing the effectiveness of T cell therapies.

Throughout the process, we collaborate closely with our clients to tailor scaffold components for their specific needs, optimizing both component concentrations and physical properties based on rigorous testing to maximize T cell activation. Our flexible service accommodates diverse research scales, from small pilot studies to large-scale initiatives. As a comprehensive provider, we also offer complete characterization services, analyzing both the phenotype and function of the developed platforms. At Creative Biolabs, our commitment is to deliver rapid, high-quality solutions that empower our clients to create more effective and durable T cell-based cancer therapies.

Attractive Features

Associated Services

Beyond immunomodulatory macroporous scaffolds, we also provide customized hydrogel-based solutions like Artificial T Cell-Stimulating Matrix (aTM) and Artificial Lymph Node (aLN) Matrix, developing advanced, tailored platforms for T cell stimulation that meet diverse client needs. Our expertise in biomaterial engineering and T cell biology allows us to design platforms mimicking specific lymphoid microenvironments, enhancing the efficacy and translatability of T cell therapies.

Creative Biolabs is a leader in advancing T cell therapies, blending in-depth scientific knowledge with practical experience in developing cutting-edge artificial T cell stimulation platforms. Please get in touch with us today to explore your project requirements and discover how our expertise in immunomodulatory macroporous scaffolds can empower you to create a highly effective artificial platform for T cell activation.

Reference

Scott, Ellen N., et al. "Regulatory T cells: barriers of immune infiltration into the tumor microenvironment." Frontiers in Immunology 12 (2021): 702726. Distributed under Open Access License CC BY 4.0, without modification.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.